Financier | Commitments |
---|---|
IDA Credit | 19.55 |
IDA Grant | 19.55 |
P174032
Closed
Zenab Konkobo Kouanda , Teegwende Porgo
Republic of Guinea
June 1, 2020
(as of board presentation)
June 17, 2020
July 28, 2020
US$ 39.10 million
Ministry of Health (Ministère de la Santé)
2020
US$ 39.10 million
N/A
Substantial
June 30, 2024
No
BANK APPROVED
June 24, 2024
Financier | Commitments |
---|---|
IDA Credit | 19.55 |
IDA Grant | 19.55 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 39.10 |
IBRD + IDA Commitment | 39.10 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 39.10 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Apr 25, 2024 | IDA-71910 | Loan Cancel | 12,520,620.00 |
Apr 25, 2024 | IDA-E1080 | Loan Cancel | 12,520,620.00 |
Jan 29, 2024 | IDA-D8940 | Loan Disb | 386,510.44 |
Jun 26, 2023 | IDA-D8940 | Loan Disb | 218,606.58 |
Dec 15, 2023 | IDA-67350 | Int Charges | 354.45 |
Dec 15, 2023 | IDA-67350 | Int Charges | 354.45 |
Oct 18, 2023 | IDA-69700 | Int Charges | 354.27 |
Oct 18, 2023 | IDA-69700 | Int Charges | 354.27 |
Oct 18, 2023 | IDA-69700 | Int Charges | 12,825.37 |
Oct 18, 2023 | IDA-69700 | Int Charges | 12,825.37 |
Nov 7, 2023 | IDA-D8940 | Loan Disb | 460,002.25 |
Nov 30, 2023 | IDA-D8940 | Loan Disb | 223,538.83 |
Jan 8, 2024 | IDA-67350 | Int Charges | 17,838.81 |
Jan 8, 2024 | IDA-67350 | Int Charges | 17,838.81 |
Apr 4, 2023 | IDA-69700 | Loan Disb | 1,313,979.10 |
Jun 1, 2023 | IDA-D8940 | Loan Disb | 600,000.00 |
Mar 5, 2021 | IDA-D6870 | Loan Disb | 1,607,651.40 |
Mar 12, 2021 | IDA-67350 | Loan Disb | 565,401.44 |
Dec 30, 2020 | IDA-D6870 | Loan Disb | 1,357,030.00 |
Mar 10, 2021 | IDA-67350 | Loan Disb | 479,456.70 |
Sep 21, 2020 | IDA-D6870 | Loan Disb | 1,000,000.00 |
Feb 23, 2021 | IDA-D6870 | Loan Disb | 920,349.75 |
Jan 14, 2021 | IDA-D6870 | Loan Disb | 357,855.70 |
Jan 11, 2021 | IDA-D6870 | Loan Disb | 488,973.28 |
Mar 9, 2021 | IDA-67350 | Loan Disb | 740,624.75 |
Jun 16, 2021 | IDA-67350 | Int Charges | 5,378.29 |
Jun 16, 2021 | IDA-67350 | Int Charges | 5,378.29 |
Jun 1, 2021 | IDA-67350 | Loan Disb | 600,000.00 |
Apr 12, 2021 | IDA-67350 | Loan Disb | 1,406,840.00 |
Jun 7, 2021 | IDA-67350 | Loan Disb | 1,515,404.10 |
Jun 17, 2020 | IDA-67350 | Loan Commitment | 5,450,000.00 |
Jun 17, 2020 | IDA-D6870 | Loan Commitment | 5,450,000.00 |
Jun 6, 2024 | IDA-69700 | Loan Disb | 3,053,667.00 |
Jun 29, 2021 | IDA-69700 | Loan Commitment | 14,100,000.00 |
Jun 29, 2021 | IDA-D8940 | Loan Commitment | 14,100,000.00 |
Jun 23, 2022 | IDA-71910 | Loan Commitment | 12,715,000.00 |
Jun 23, 2022 | IDA-E1080 | Loan Commitment | 12,715,000.00 |
Jun 15, 2024 | IDA-67350 | Int Charges | 18,281.90 |
Jun 15, 2024 | IDA-67350 | Int Charges | 18,281.90 |
May 20, 2024 | IDA-69700 | Loan Disb | 1,140,728.10 |
Jun 28, 2024 | IDA-69700 | Loan Disb | 223,022.70 |
Jun 7, 2024 | IDA-69700 | Loan Disb | 300,000.00 |
Apr 8, 2024 | IDA-69700 | Loan Disb | 1,500,000.00 |
Jun 15, 2024 | IDA-67350 | Int Charges | 359.26 |
Jun 15, 2024 | IDA-67350 | Int Charges | 359.26 |
Jun 7, 2024 | IDA-69700 | Loan Disb | 567,304.25 |
Jun 27, 2024 | IDA-69700 | Loan Disb | 961,176.00 |
May 23, 2024 | IDA-69700 | Loan Disb | 597,065.56 |
Apr 15, 2024 | IDA-69700 | Int Charges | 213.09 |
Apr 15, 2024 | IDA-69700 | Int Charges | 213.09 |
Apr 15, 2024 | IDA-69700 | Int Charges | 12,906.94 |
Apr 15, 2024 | IDA-69700 | Int Charges | 12,906.94 |
Feb 29, 2024 | IDA-D8940 | Loan Disb | 87,113.19 |
Mar 12, 2024 | IDA-69700 | Loan Disb | 300,000.00 |
Mar 20, 2024 | IDA-69700 | Loan Disb | 400,000.00 |
Apr 25, 2024 | IDA-69700 | Loan Cancel | 432,290.88 |
Jul 3, 2023 | IDA-67350 | Int Charges | 753.88 |
Jul 3, 2023 | IDA-67350 | Int Charges | 753.88 |
Jul 3, 2023 | IDA-67350 | Int Charges | 18,473.24 |
Jul 3, 2023 | IDA-67350 | Int Charges | 18,473.24 |
Apr 28, 2023 | IDA-D6870 | Loan Disb | -95,389.44 |
Mar 3, 2023 | IDA-D8940 | Loan Disb | 195,000.02 |
Apr 13, 2023 | IDA-69700 | Loan Disb | 1,519,732.00 |
Apr 27, 2023 | IDA-69700 | Loan Disb | 160,323.00 |
Apr 27, 2023 | IDA-69700 | Loan Disb | 201,397.02 |
Apr 27, 2023 | IDA-69700 | Loan Disb | 375,881.00 |
Dec 16, 2021 | IDA-67350 | Int Charges | 19,414.07 |
Dec 16, 2021 | IDA-67350 | Int Charges | 19,414.07 |
Dec 16, 2021 | IDA-67350 | Int Charges | 455.02 |
Dec 16, 2021 | IDA-67350 | Int Charges | 455.02 |
Jan 28, 2022 | IDA-D8940 | Loan Disb | 1,000,000.00 |
Dec 15, 2022 | IDA-67350 | Int Charges | 480.28 |
Dec 15, 2022 | IDA-67350 | Int Charges | 480.28 |
Dec 15, 2022 | IDA-67350 | Int Charges | 17,248.93 |
Dec 15, 2022 | IDA-67350 | Int Charges | 17,248.93 |
Dec 14, 2022 | IDA-D8940 | Loan Disb | 411,640.80 |
Jun 15, 2022 | IDA-67350 | Int Charges | 18,297.56 |
Jun 15, 2022 | IDA-67350 | Int Charges | 18,297.56 |
Jun 15, 2022 | IDA-67350 | Int Charges | 199.99 |
Jun 15, 2022 | IDA-67350 | Int Charges | 199.99 |
Apr 12, 2022 | IDA-D8940 | Loan Disb | 9,770,041.00 |
Name | Review | Date |
---|---|---|
Progress towards achievement of PDO | Satisfactory | 2024-05-10 |
Procurement | Satisfactory | 2024-05-10 |
Monitoring and Evaluation | Moderately Satisfactory | 2024-05-10 |
Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-05-10 |
Project Management | Moderately Satisfactory | 2024-05-10 |
Financial Management | Satisfactory | 2024-05-10 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Suspected cases of COVID-19 cases reported and investigated based on national guidelines | Value | 400.00 | 19143.00 | 1000.00 |
Date | July 28, 2020 | July 31, 2022 | July 31, 2022 | |
Comment |
Designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents | Value | 4.00 | 12.00 | 8.00 |
Date | July 28, 2020 | July 31, 2022 | July 31, 2022 | |
Comment |
Acute healthcare facilities with isolation capacity | Value | 7.90 | 100.00 | 90.00 |
Date | July 28, 2020 | July 31, 2022 | July 31, 2022 | |
Comment |
Population fully vaccinated, which is included in the priority population targets defined in the national plan, by gender | Value | 0.00 | 45.00 | 50.00 |
Date | April 16, 2021 | May 5, 2024 | June 30, 2025 | |
Comment |
Women fully vaccinated, which is included in the priority population targets defined in the national plan | Value | 0.00 | 47.00 | 50.00 |
Date | April 16, 2021 | May 5, 2024 | June 30, 2025 | |
Comment |
Enta Nord Regional Hospital completed and operational | Value | No | No | Yes |
Date | June 26, 2023 | May 5, 2024 | June 30, 2025 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
M&E system established to monitor COVID-19 preparedness and response plan | Value | No | Yes | Yes |
Date | July 28, 2020 | May 5, 2024 | June 30, 2025 | |
Comment |
Health staff trained in infection prevention and control per MOH-approved protocols | Value | 0.00 | 1204.00 | 1400.00 |
Date | July 28, 2020 | May 5, 2024 | June 30, 2025 | |
Comment |
Vaccination sites that transmit their data via DHIS2 | Value | 0.00 | 100.00 | 100.00 |
Date | April 16, 2021 | May 5, 2024 | June 30, 2025 | |
Comment |
Designated laboratories with staff trained to conduct COVID-19 diagnosis | Value | 4.00 | 12.00 | 8.00 |
Date | July 28, 2020 | July 31, 2022 | July 31, 2022 | |
Comment |
Number of health facilities including CT-EPI equipped | Value | 0.00 | 33.00 | 30.00 |
Date | June 26, 2023 | May 5, 2024 | June 30, 2025 | |
Comment |
HMIS collecting sex and age disaggregated data on COVID-19 indicators for testing, treatment, and vaccines | Value | No | Yes | Yes |
Date | April 16, 2021 | May 5, 2024 | June 30, 2025 | |
Comment |
Country has prepared guidelines to care for COVID-19 patients | Value | No | Yes | Yes |
Date | July 28, 2020 | July 31, 2022 | July 31, 2022 | |
Comment |
Number of community health staff trained in community-based surveillance | Value | 0.00 | 0.00 | 3000.00 |
Date | June 26, 2023 | May 5, 2024 | June 30, 2025 | |
Comment |
Vaccinators trained on GBV/SEA/SH | Value | 0.00 | 0.00 | 95.00 |
Date | April 16, 2021 | May 5, 2024 | June 30, 2025 | |
Comment |
Start-ups recruited for the development of innovative and digital technology solution for accelerated COVID-19 prevention and response | Value | 0.00 | 4.00 | 5.00 |
Date | July 28, 2020 | July 31, 2022 | July 31, 2022 | |
Comment |
Grievances addressed within the time specified in the project implementation manual | Value | 0.00 | 100.00 | 80.00 |
Date | July 28, 2020 | May 5, 2024 | June 30, 2025 | |
Comment |
Key gender-responsive messages and materials developed for public communications and advocacy, in alignment with demand plan | Value | No | Yes | Yes |
Date | April 16, 2021 | May 5, 2024 | June 30, 2025 | |
Comment |
Cold rooms fully equipped | Value | 0.00 | 0.00 | 8.00 |
Date | April 16, 2021 | May 5, 2024 | June 30, 2025 | |
Comment |
Health regions with a functional AEFI monitoring committee | Value | 0.00 | 100.00 | 100.00 |
Date | April 16, 2021 | May 5, 2024 | June 30, 2025 | |
Comment |
Beneficiaries reporting that community engagement and outreach meet their needs | Value | 0.00 | 0.00 | 50.00 |
Date | April 16, 2021 | May 5, 2024 | June 30, 2025 | |
Comment |
Adolescents fully vaccinated, which is included in the priority population targets defined in the national plan | Value | 1.40 | 10.00 | 15.00 |
Date | May 25, 2022 | May 5, 2024 | June 30, 2025 | |
Comment |
Population receiving a booster, which is included in the population targets defined in the national plan | Value | 0.00 | 30.00 | 30.00 |
Date | May 25, 2022 | May 5, 2024 | June 30, 2025 | |
Comment |